#esmo21 highlights on a phase i of dual raf/mek inhibitor fak inhibitor in ovarian cancer (frame)
Published 3 years ago • 999 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
2:18
#esmo21 highlights on maintenance olaparib in ovarian cancer previously treated with parpi
-
6:14
standard of care and progress with parp inhibitors for ovarian cancer
-
2:37
#esmo22 highlights on abemaciclib nsai in hr /her2- advanced breast cancer: the monarch 3 study
-
2:03
on the scene at #sgomtg: ovarian cancer research highlights
-
1:02
breast and gynecological cancer highlights at esmo immuno-oncology 2022
-
6:57
upcoming clinical trials for ovarian cancer
-
18:16
ovarian cancer awareness: mayo clinic radio
-
8:25
what should i do if i think i have ovarian cancer?
-
2:50
esmo 2015 highlights: putting ovarian cancer management into perspective
-
39:49
advancing our understanding of nervous system disorders - isscr 2021 innovation showcase
-
50:02
recurrent ovarian cancer (2022)
-
5:38
management of parp inhibitor aes in ovarian cancer
-
4:54
impact of solo-1 on advanced ovarian cancer management
-
5:37
metastatic breast cancer at esmo 2022: tropics02, monarch 3 and synergy
-
5:28
ovarian cancer awareness month
-
1:31
esmo oncologypro - intro by prof. a. matikas
-
0:56
musc hollings gynecologist oncologist on ovarian cancer awareness
-
28:33
michael j. birrer md, phd: future of ovarian cancer treatment: personalized medicine
-
20:21
the importance of ovarian cancer awareness with aradhana m. venkatesan, md